The performance of companies tied to the drug's past presents a challenging investment landscape. While the initial boom generated substantial returns , generic copies have significantly diminished revenue. https://online-pharmacy493407.ampedpages.com/copyright-s-flagship-product-and-pharma-a-risky-opportunity-68804134